Repligen (RGEN) Tops Q3 EPS by 4c ; Offers Guidance
Tweet
Share
E-mailGet Alerts RGEN Hot Sheet
Price: $121.73 +0.50%
EPS Growth %: +21.6%
Financial Fact:
(Loss) income from operations: 3.75M
Today's EPS Names:
CRMT, REPL, HURC, More
EPS Growth %: +21.6%
Financial Fact:
(Loss) income from operations: 3.75M
Today's EPS Names:
CRMT, REPL, HURC, More
Join SI Premium – FREE
Repligen (NASDAQ: RGEN) reported Q3 EPS of $0.46, $0.04 better than the analyst estimate of $0.42. Revenue for the quarter came in at $189 million versus the consensus estimate of $181.78 million.
GUIDANCE:
Repligen sees FY2025 EPS of $1.65-$1.68, versus the consensus of $1.69. Repligen sees FY2025 revenue of $729-737 million, versus the consensus of $727.8 million.
For earnings history and earnings-related data on Repligen (RGEN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- IDT Corp. (IDT) Tops Q3 EPS by 2c; offer guidance
- RBC Capital on Veeva Systems (VEEV) Amid After Hours Selloff on Earnings: 'we are surprised to see shares trade down'
- Wolfe Research Assumes Repligen (RGEN) at Outperform
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
